Trials / Completed
CompletedNCT02877160
A Study to Assess the PK of AL-794 Formulations in Healthy Subjects
A Phase 1, Single-Center, Randomized, Open-Label, Single-Dose, Crossover Study to Assess the Pharmacokinetics, Including Food Effect, of AL-794 Formulations in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Alios Biopharma Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study is a single-center, randomized, open-label crossover study to assess the pharmacokinetics and food effect of AL-794 formulations in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AL-794 suspension | |
| DRUG | AL-794 tablet |
Timeline
- Start date
- 2016-06-30
- Primary completion
- 2017-02-28
- Completion
- 2017-05-31
- First posted
- 2016-08-24
- Last updated
- 2017-06-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02877160. Inclusion in this directory is not an endorsement.